Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

351 Views

Z2. COVID-19 Infection prevention

Poster Session: COVID-19: Infection Prevention

(P-1969) Safety, Immunogenicity, and Pharmacokinetics of Repeat Dosing with AZD7442 (Tixagevimab/Cilgavimab): Final Analysis of the ENDURE Phase 2, Dose-Ranging Study in Immunocompromised Participants

Saturday, October 19, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Taylor Cohen, PhD

Global Project Lead
AstraZeneca
Gaithersburg, Maryland, United States

Co-Author(s)

MV

Marimer Rensoli Valzquez, MD

Charisme Medical and Research Center
Miami Lakes, Florida, United States
CM

Chigo Munthali, MBBS, MSc, DPM, MFPM, CCT(Pharma Med.)

AstraZeneca
Cambridge, England, United Kingdom
HK

Herve Tchouakam Kouekam, MSc

AstraZeneca
Toronto, Ontario, Canada
SM

Sam Matthews, MSc

AstraZeneca
Cambridge, England, United Kingdom
AS

Audrey Sharbaugh, PhD

AstraZeneca
Durham, North Carolina, United States
RB

Rohini Beavon, PhD

AstraZeneca
Cambridge, England, United Kingdom
DW

Dilki Wickramarachchi, PhD

AstraZeneca
Gaithersburg, Maryland, United States
SO

Sharon Otal, HBSc, MBA

AstraZeneca
Mississauga, Ontario, Canada
HY

Haitao Yang, PhD

AstraZeneca
Gaithersburg, Maryland, United States
Anastasia A. Aksyuk, PhD

Director
Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA
Gaithersburg, MD, United States
Lindsay E. Clegg, PhD (she/her/hers)

Associate Director, Clinical Pharmacology and Pharmacometrics
AstraZeneca
Gaithersburg, Maryland, United States
HZ

Huixia Zhang, PhD

AstraZeneca
Gaithersburg, Maryland, United States
AN

Antonella Nadia Tuillio, MD

AstraZeneca
Gaithersburg, Maryland, United States
SS

Seth Seegobin, PhD

AstraZeneca
Cambridge, England, United Kingdom
Katie Streicher, PhD (she/her/hers)

Head of Translational Medicine, Vaccines and Immune Therapies
AstraZeneca
Gaithersburg, Maryland, United States
DW

David Wheeler, MD

CARE-ID
Annandale, Virginia, United States
Lee-Jah Chang, MD (he/him/his)

Vice President, Clinical Development, Vaccines and Immune Therapies
AstraZeneca
Gaithersburg, Maryland, United States
HM

Hugh Montgomery, MD

University College London
London, England, United Kingdom